Mark S. Leventhal, Director at ProPhase Labs, Inc. (PRPH), bought 14,248 shares at $1.55 ($22K) on 2015-11-27, disclosed to the SEC on 2015-12-08.
Open-market purchase of $22k PRPH by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.55 | 13,300 | $21K | 93.6% |
| 2 | $1.48 | 948 | $1K | 6.4% |
| Total | $1.55 avg | 14,248 | $22K | 100% |
| Filing → |
| PRPH | BUY | 2012-11-30 | $231K | — | Filing → |